| Tretinoin | Approved Investigational Nutraceutical | P3H2 | 55214 |
upregulated | Tretinoin results in increased expression of P3H2 mRNA | 3q28 | |
| Tretinoin | Approved Investigational Nutraceutical | P4HA2 | 8974 |
upregulated | Tretinoin results in increased expression of P4HA2 mRNA | 5q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | PA2G4 | 5036 |
downregulated | Tretinoin results in decreased expression of PA2G4 mRNA | 12q13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | PABPC4L | 132430 |
upregulated | Tretinoin results in increased expression of PABPC4L mRNA | 4q28.3 | |
| Tretinoin | Approved Investigational Nutraceutical | PACSIN1 | 29993 |
downregulated | Tretinoin results in decreased expression of PACSIN1 mRNA | 6p21.3 | |
| Tretinoin | Approved Investigational Nutraceutical | PADI2 | 11240 |
upregulated | Tretinoin results in increased expression of PADI2 mRNA | 1p36.13 | |
| Tretinoin | Approved Investigational Nutraceutical | PAF1 | 54623 |
upregulated | Tretinoin results in increased expression of PAF1 mRNA | 19q13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | PAGR1 | 79447 |
downregulated | Tretinoin results in decreased expression of PAGR1 mRNA | 16p11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | PAICS | 10606 |
downregulated | Tretinoin results in decreased expression of PAICS mRNA | 4q12 | |
| Tretinoin | Approved Investigational Nutraceutical | PAIP1 | 10605 |
upregulated | Tretinoin results in increased expression of PAIP1 mRNA | 5p12 | |
| Tretinoin | Approved Investigational Nutraceutical | PAIP2 | 51247 |
downregulated | Tretinoin results in decreased expression of PAIP2 mRNA | 5q31.2 | |
| Tretinoin | Approved Investigational Nutraceutical | PAK1 | 5058 |
upregulated | Tretinoin results in increased expression of PAK1 mRNA | 11q13.5-q14.1 | |
| Tretinoin | Approved Investigational Nutraceutical | PAK2 | 5062 |
downregulated | Tretinoin results in decreased expression of PAK2 mRNA | 3q29 | |
| Tretinoin | Approved Investigational Nutraceutical | PAK3 | 5063 |
downregulated | Tretinoin results in decreased expression of PAK3 mRNA | Xq23 | |
| Tretinoin | Approved Investigational Nutraceutical | PALLD | 23022 |
downregulated | Tretinoin results in decreased expression of PALLD mRNA | 4q32.3 | |
| Tretinoin | Approved Investigational Nutraceutical | PALLD | 23022 |
upregulated | Tretinoin results in increased expression of PALLD mRNA | 4q32.3 | |
| Tretinoin | Approved Investigational Nutraceutical | PALM2-AKAP2 | 445815 |
downregulated | Tretinoin results in decreased expression of PALM2-AKAP2 mRNA | 9q31.3 | |
| Tretinoin | Approved Investigational Nutraceutical | PAMR1 | 25891 |
downregulated | Tretinoin results in decreased expression of PAMR1 mRNA | 11p13 | |
| Tretinoin | Approved Investigational Nutraceutical | PANK3 | 79646 |
downregulated | Tretinoin results in decreased expression of PANK3 mRNA | 5q34 | |
| Tretinoin | Approved Investigational Nutraceutical | PAPLN | 89932 |
downregulated | Tretinoin results in decreased expression of PAPLN mRNA | 14q24.2 | |
| Tretinoin | Approved Investigational Nutraceutical | PAPOLA | 10914 |
downregulated | Tretinoin results in decreased expression of PAPOLA mRNA | 14q32.2 | |
| Tretinoin | Approved Investigational Nutraceutical | PAPPA | 5069 |
downregulated | Tretinoin results in decreased expression of PAPPA mRNA | 9q33.1 | |
| Tretinoin | Approved Investigational Nutraceutical | PAPPA2 | 60676 |
upregulated | Tretinoin results in increased expression of PAPPA2 mRNA | 1q25.2 | |
| Tretinoin | Approved Investigational Nutraceutical | PAPSS2 | 9060 |
upregulated | Tretinoin results in increased expression of PAPSS2 mRNA | 10q23.2-q23.31 | |
| Tretinoin | Approved Investigational Nutraceutical | PAQR8 | 85315 |
downregulated | Tretinoin results in decreased expression of PAQR8 mRNA | 6p12.2 | |